Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester, commonly known as "Telmisartan tert-butyl isocyanate," is a pharmaceutical ingredient derived from the medication telmisartan, which is used to treat high blood pressure. N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester features a pyrazole ring and a carbamic acid tert-butyl ester group, which are essential for its biological activity.

689293-69-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester

    Cas No: 689293-69-4

  • USD $ 3.0-3.0 / Kilogram

  • 1 Kilogram

  • 1-100 Metric Ton/Month

  • Dayang Chem (Hangzhou) Co.,Ltd.
  • Contact Supplier
  • High purity CAS 689293-69-4 N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester in stock

    Cas No: 689293-69-4

  • USD $ 100.0-100.0 / Gram

  • 1 Gram

  • 1000 Metric Ton/Day

  • HENAN NEW BLUE CHEMICAL CO.,LTD
  • Contact Supplier
  • tert-butyl N-{2-[({1-methyl-5-[(triphenylmethyl)amino]pyrazol-4-yl}carbamoyl)amino]ethyl}carbamate

    Cas No: 689293-69-4

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • Lower Price N-[2-[[[[1-Methyl-5-[(Triphenylmethyl)Amino]-1H-Pyrazol-4-yl]amino]carbonyl]ethyl]carbamic Acid Tert-Butyl Ester on stock

    Cas No: 689293-69-4

  • No Data

  • 1 Kilogram

  • 15000 Kilogram/Year

  • Siwei Development Group Ltd.
  • Contact Supplier
  • N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester

    Cas No: 689293-69-4

  • USD $ 10.0-10.0 / Milligram

  • 1 Milligram

  • 100000000 Kilogram/Month

  • weifang yangxu group co.,ltd
  • Contact Supplier
  • 689293-69-4 Structure
  • Basic information

    1. Product Name: N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester
    2. Synonyms: N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester;tert-Butyl [2-({[1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]carbamoyl}amino)ethyl]carbamate;tert-butyl [2-({[1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]carbamoyl}amino)ethyl]carbamate (Related Reference);tert-butyl (2-(3-(1-methyl-5-(tritylamino)-1H-pyrazol-4-yl)ureido)ethyl)carbamate;Carbamic acid, N-[2-[[[[1-methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]-, 1,1-dimethylethyl ester
    3. CAS NO:689293-69-4
    4. Molecular Formula: C31H36N6O3
    5. Molecular Weight: 540.65594
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 689293-69-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 680.391°C at 760 mmHg
    3. Flash Point: 365.288°C
    4. Appearance: /
    5. Density: 1.17
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.603
    8. Storage Temp.: 2-8°C(protect from light)
    9. Solubility: N/A
    10. PKA: 12.29±0.46(Predicted)
    11. CAS DataBase Reference: N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester(CAS DataBase Reference)
    12. NIST Chemistry Reference: N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester(689293-69-4)
    13. EPA Substance Registry System: N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester(689293-69-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 689293-69-4(Hazardous Substances Data)

689293-69-4 Usage

Uses

Used in Pharmaceutical Industry:
N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester is used as a reagent in chemical synthesis for the production of telmisartan, a medication for treating high blood pressure. Its unique chemical structure, including the pyrazole ring and carbamic acid tert-butyl ester group, plays a crucial role in the synthesis process, making it an essential component in the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 689293-69-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,9,2,9 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 689293-69:
(8*6)+(7*8)+(6*9)+(5*2)+(4*9)+(3*3)+(2*6)+(1*9)=234
234 % 10 = 4
So 689293-69-4 is a valid CAS Registry Number.
InChI:InChI=1/C31H36N6O3/c1-30(2,3)40-29(39)33-21-20-32-28(38)35-26-22-34-37(4)27(26)36-31(23-14-8-5-9-15-23,24-16-10-6-11-17-24)25-18-12-7-13-19-25/h5-19,22,36H,20-21H2,1-4H3,(H,33,39)(H2,32,35,38)

689293-69-4Downstream Products

689293-69-4Relevant articles and documents

Preparation method of carbamyl amino pyrazol derived compound

-

, (2019/03/08)

The invention relates to a preparation method of a carbamyl amino pyrazol derived compound, belongs to the technical field of drug intermediates and aims to solve the problem that an existing synthetic route is complicated and is uneasy to operate. The preparation method of the carbamyl amino pyrazol derived compound comprises the steps that in the presence of an acid-binding agent, a compound shown in a formula II and triphenyl halomethane perform condensation reaction in an organic solvent to obtain an intermediate product compound shown in a formula III; then, in the presence of inorganic base, the compound shown in the formula III is subjected to ester hydrolysis reaction, and a compound shown in a formula IV is obtained; the compound and trinitride perform Curtius rearrangement reaction to obtain a compound shown in a formula V; the compound shown in the formula V and BoxEDA perform condensation reaction to obtain the carbamyl amino pyrazol derived compound. The preparation methodhas the advantages that raw materials are easy to obtain, a reaction route operation is simple, and the product yield and purity are high.

PROCESS FOR THE PREPARATION OF CARBAMOYLAMINO PYRAZOLE DERIVATIVES

-

, (2017/01/23)

The present invention relates to a process for the preparation of carbamoylamino pyrazole derivatives using diacetoxyiodobenzene (ΡhΙ(ΟΑc)2) in combination with a non-nucleophilic base.

INTERMEDIATES IN THE SYNTHESIS OF CEPHALOSPORIN COMPOUNDS

-

Sheet 3, (2016/02/29)

Described herein are crystalline forms of a compound of formula (ΙΙΓ), including toluene solvates ofT A TD-CLE, as well as processes for the preparation thereof and use thereof in the preparation of cephalosporin compounds such as ceftolozane. Provided he

Synthesis and SAR of novel parenteral anti-pseudomonal cephalosporins: Discovery of FR264205

Toda, Ayako,Ohki, Hidenori,Yamanaka, Toshio,Murano, Kenji,Okuda, Shinya,Kawabata, Kohji,Hatano, Kazuo,Matsuda, Keiji,Misumi, Keiji,Itoh, Kenji,Satoh, Kenji,Inoue, Satoshi

scheme or table, p. 4849 - 4852 (2009/05/07)

We describe herein the synthesis and biological evaluation of a series of novel cephalosporins with potent activity against Pseudomonas aeruginosa. Introduction of various amino groups to the 4-position of a 3-amino-2-methylpyrazole cephalosporin 3-side c

CEPHEM COMPOUNDS

-

Page 35, (2010/02/06)

The present invention relates to a compound of the formula [I]: wherein R1 is lower alkyl, hydroxy(lower)alkyl or halo(lower)alkyl, and R2 is hydrogen or amino protecting group, or R1 and R2 are bonded together and form lower alkylene or lower alkenylene; R3 is hydrogen or lower alkyl; R4 is ; R5 is carboxy or protected carboxy; and R6 is amino or protected amino, or a pharmaceutically acceptable salt thereof, a process for preparing a compound of the formula [I], and a pharmaceutical composition comprising a compound of the formula [I] in admixture with a pharmaceutically acceptable carrier.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 689293-69-4